CABA CIK: 1759138

Cabaletta Bio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−46.3
FY22:
−54.1
FY23:
−74.7
FY24:
−125
FY25:
−172
(positive)
Change from FY21 to FY25
millions USD
FY21:
−45.6
FY22:
−53.0
FY23:
−73.2
FY24:
−113
FY25:
−164
(positive)
Change from FY21 to FY25
millions USD
FY21:
−46.3
FY22:
−53.0
FY23:
−67.7
FY24:
−116
FY25:
−168
(positive)
Change from FY21 to FY25
millions USD
FY21:
−46.3
FY22:
−53.0
FY23:
−67.7
FY24:
−116
FY25:
−168

All amounts in millions USD Data sources:SEC EDGARTwelve Data